The Open Endocrinology Journal
2009, 3 : 38-41Published online 2009 October 15. DOI: 10.2174/1874216500903010038
Publisher ID: TOEJ-3-38
Bromocriptine Response in Pathological Hyperprolactinemia: A 34 Year Follow-Up of a Homogeneous Population of 827 Patients
Department of Medicine,
Division of Endocrinology and Metabolism, The University of Calgary,
Calgary, Alberta, Canada.
ABSTRACT
827 patients with symptomatic pathological hyperprolactinemia were treated with bromocriptine. The evaluation, treatment, and follow-up was by a single individual, making this a large and unique homogeneous group for purposes of treatment evaluation.